The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours

International Journal of Hyperthermia

Volumn 19, Issue 2, 2003, Pages 193-203

  Takemoto, M ^a   Kuroda, M ^a   Urano, M ^b   Nishimura, Y ^c   Kawasaki, S ^a   Kato, H ^a   Okumura, Y ^a   Akaki, S ^a   Kanazawa, S ^a   Asaumi, J ^d   Joja, I ^a   Hiraki, Y ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c KINKI UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Animal tumours; Chemotherapy; Mild hyperthermia; Thermal enhancement; Thermochemotherapy

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; IFOSFAMIDE; MELPHALAN; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CALCULATION; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL TRANSPLANTATION; GROWTH INHIBITION; HYPERTHERMIC THERAPY; MAXIMUM TOLERATED DOSE; MOUSE; MOUSE STRAIN; MULTIMODALITY CANCER THERAPY; NONHUMAN; OSTEOSARCOMA; ROOM TEMPERATURE; SQUAMOUS CELL CARCINOMA; THERMAL ANALYSIS; TIME; TUMOR; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL;

EID: 0037335525     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/0265673021000035235     Document Type: Article

References (34)

1. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-8.
2. Marmor JB. Interactions of hyperthermia and chemotherapy in animals. Cancer Res 1979; 39: 2269-76.
3. Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15: 79-107
4. Gerard H, Van Echo DA, Whitacre M, Ashman M, Helrich M, Foy J, Ostrow S, Wiernik PH, Aisner J. Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma. Cancer 1984; 53: 2585-91.
5. Storm FK, Baker HW, Scanlon EF, Plenk HP, Meadows PM, Cohen SC, Olson CE, Thomson JW, Khandekar JD, Roe D, Nizze A, Morton DL. Magnetic-induction hyperthermia: Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients. Cancer 1985; 55: 2677-87.
6. Baba H, Siddik ZH, Strebel FR, Jenken GN, Bull JMC. Increased therapeutic gain of combined cis-diamminedichloroplatinum(II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Res 1989; 49: 7041-4.
7. Bull JM, Cronau LH, Newman BM, Jabboury K, Allen SJ, Ohno S, Smith T, Tonnesen AS. Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Int J Hyperthermia 1992; 8: 297-304.
8. Leinard D, Ewalenko P, Delmotte J-J, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992; 10: 52-60.
9. Alexander HR, Fraker DL, Bartlett DL. Isolated limb perfusion for malignant melanoma. Semin Surg Oncol 1996; 12: 416-28.
10. Urano M, Kahn J, Kenton LA. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 1990; 6: 563-70.
11. Wiedemann G, Roszinski S, Biersack A, Weiss C, Wagner T. Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 1992; 118: 129-35.
12. Honess DJ. Thermal potentiation of alkylating agent toxicity in tumors in vivo. In: Urano M, Douple EB, eds. Chemopotentiation by Hyperthermia (Hyperthermia and Oncology, Vol. 4).
13. Urano M, Kahn J, Majima H, Gerweck LE. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int J Hyperthermia 1990; 6: 581-90.
14. Urano M, Kahn J, Reynolds R. The effect of 5-fluorouracil at elevated temperatures on a spontaneous mouse tumour; Arrhenius analysis and tumour response. Int J Radiat Biol 1991; 59: 239-49.
15. Urano M, Majima H, Kahn J. Cytotoxic effect of 1,3 bis(2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumour response. Int J Hyperthermia 1991; 7: 499-510.
16. Urano M, Kim MS. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma. Cancer Res 1983; 43: 3041-4.
17. Honess DJ, Bleehen NM. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: Therapeutic gain for melphalan only. Br J Radiol 1985; 58: 63-72.
18. Kuroda M, Urano M, Reynolds R. Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II. Int J Hyperthermia 1997; 13: 125-31.
19. Overgaard J. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res 1976; 36: 3077-81.
20. Urano N, Begley J, Reynolds R. Interaction between adriamycin cytotoxicity and hyperthermia: Growth-phase-dependent thermal sensitization. Int J Hyperthermia 1994; 10: 817-26.
21. Bosanquet AG. Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. Cancer Chemother Pharmacol 1985; 14: 83-95.
22. Parsons PG. Dependence on treatment time of melphalan resistance and DNA crosslinking in human melanoma cell lines. Cancer Res 1984; 44: 2773-8.
23. Tofilon PJ, Da Silva V, Gutin PH, Deen DF. Effects of hyperthermia on DNA interstrand crosslinking after treatment with BCNU in 9L rat brain tumor cells. Radiat Res 1985; 103: 373-82.
24. Zaffaroni N, Villa R, Orlandi L, Vaglini M, Silvestrini R. Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanoma. Int J Hyperthermia 1992; 8: 341-9.
25. Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxity in vitro. Int J Hyperthermia 2002; 18: 307-15.
26. Eggermont AMM, Koops HS, Lienard D, Kroon BBR, Van Geel AN, Hoekstra HJ, Lejeune FJ. Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial. J. Clin Oncol 1996; 14: 2653-65.
27. Mulcahy RT, Gipp JJ, Tanner MA. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41°C) in vitro and selective enhancement in vivo. Int J Radiat Biol Rel Stud Phys Chem Med 1987; 52: 57-65.
28. Wiedemann GJ, Siemens HJ, Mentzel M, Biersack A, Wossmann W, Knocks D, Weiss C, Wagner T. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Res 1993; 53: 4268-72.
29. Lindegaard JC, Radacic M, Khalil AA, Horsman MR, Overgaard J. Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Acta Oncolog 1992; 31: 347-51.
30. Meyn RE, Corry PM, Fletcher SE, Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 1980; 40: 1136-9.
31. Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation. Int J Hyperthermia 1991; 7: 773-84.
32. Pinto AL, Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophus Acta 1985; 780: 167-80.
33. Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Nat Acad Sci (USA) 1987; 84: 5024-8.
34. Urano M, Kahn J. The effect of bleomycin administered in combination with hyperthermia on a C3H mouse fibrosarcoma. Int J Hyperthermia 1989; 5: 377-82.